by
Gus Iversen, Editor in Chief | December 04, 2024
Bracco's Max 3 MR injector
Syringeless MR injector gets FDA OK
Bracco Diagnostics Inc., the New Jersey-based subsidiary of Bracco Imaging S.p.A.,
announced FDA clearance for the Max 3 Rapid Exchange and Syringeless Injector during RSNA.
Max 3, which is manufactured by Ulrich and distributed under separate licensing agreements with Bracco
and GE HealthCare, introduces features aimed at enhancing efficiency and usability in MR workflows. Notably, it allows direct injection from contrast media vials, eliminating the need for syringe refills. The device, free from power cables, can be positioned anywhere in MR rooms with magnetic field strengths up to 50mT.
Ad Statistics
Times Displayed: 109208
Times Visited: 6638 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Combined with Bracco's VUEWAY contrast agent, which requires
half as much gadolinium as other macrocyclic GBCAs, the injector represents a solid step forward for sustainability.
For GE, the MR Max 3 is the second syringeless power injector solution, following the
launch of the CT Motion injector at RSNA in 2022, which is also licensed via Ulrich.
Siemens Healthineers at RSNA 2024
For at least one OEM, the future of CT is photon-counting
When it comes to CT, Siemens Healthineers placed a clear bet at RSNA this year. The company introduced not one, but
an entire family of photon-counting CE scanners, called the Naeotom Alpha class.
The lineup includes the Naeotom Alpha.Pro, a dual-source scanner for high-demand imaging environments; the Naeotom Alpha.Prime, which is geared toward emergency and inpatient care and is the world’s first single-source photon-counting CT scanner; and a rebrand of the original Naeotom Alpha,
launched in 2021, as Naeotom Alpha.Peak.
Photon-counting CT provides high-res imaging by counting individual X-ray photons, allowing for detailed anatomical and functional imaging at lower radiation doses. The technology also enhances diagnostic accuracy and reduces artifacts, meaning faster clinical decision-making and optimized workflows.
Perhaps when the industry comes together for RSNA 2030, veteran attendees will reminisce about the days when CT manufacturers were still building scanners that did
not have photon-counting capabilities?
Back to HCB News
